CEACAM5 and neoplasm: We conducted receiver operating characteristic (ROC) curve analysis to evaluate the diagnostic performance of our selected miRNAs (miR-19b, miR-21, and miR-145) and the protein tumor biomarkers CEA and CYFRA 21-1.